Familial chylomicronemia syndrome: case reports of siblings with deletions of the GPIHBP1 gene.

Autor: Kim KY; Department of Pediatrics, Catholic Kwandong University International St. Mary's Hospital, Incheon, Korea., Heo YJ; Department of Pediatrics, Gwangmyeong Hospital, Chung-Ang University School of Medicine, Gwangmyeong, South Korea., Ko JM; Department of Pediatrics, Seoul National University Children's Hospital, Seoul, Korea., Lee YA; Department of Pediatrics, Seoul National University Children's Hospital, Seoul, Korea., Shin CH; Department of Pediatrics, Seoul National University Children's Hospital, Seoul, Korea., Ki CS; GC Genome, Yongin, Korea., Lee YJ; Department of Pediatrics, Seoul National University Children's Hospital, Seoul, Korea. yjlee103@snu.ac.kr.
Jazyk: angličtina
Zdroj: BMC endocrine disorders [BMC Endocr Disord] 2024 Apr 15; Vol. 24 (1), pp. 47. Date of Electronic Publication: 2024 Apr 15.
DOI: 10.1186/s12902-024-01574-9
Abstrakt: Background: Familial chylomicronemia syndrome (FCS) is a rare monogenic form of severe hypertriglyceridemia, caused by mutations in genes involved in triglyceride metabolism. Herein, we report the case of a Korean family with familial chylomicronemia syndrome caused by compound heterozygous deletions of glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 (GPIHBP1).
Case Presentation: A 4-year-old boy was referred for the evaluation of severe hypertriglyceridemia (3734 mg/dL) that was incidentally detected 4 months prior. His elder brother also demonstrated an elevated triglyceride level of 2133 mg/dL at the age of 9. Lipoprotein electrophoresis revealed the presence of chylomicrons, an increase in the proportion of pre-beta lipoproteins, and low serum lipoprotein lipase levels. The patient's parents and first elder brother had stable lipid profiles. For suspected FCS, genetic testing was performed using the next-generation sequencing-based analysis of 31 lipid metabolism-associated genes, which revealed no pathogenic variants. However, copy number variant screening using sequencing depth information suggested large heterozygous deletion encompassing all the coding exons of GPIHBP1. A real-time quantitative polymerase chain reaction was performed to validate the deletion site. The results showed that the siblings had two heterozygous copy number variants consisting of the whole gene and an exon 4 deletion, each inherited from their parents. During the follow-up period of 17 months, the patient did not develop pancreatitis, following dietary intervention.
Conclusion: These siblings' case of familial chylomicronemia syndrome caused by rare GPIHBP1 deletions highlight the implementation of copy number variants-beyond next-generation sequencing-as an important consideration in diagnosis. Accurate genetic diagnosis is necessary to establish the etiology of severe hypertriglyceridemia, which increases the risk of pancreatitis.
(© 2024. The Author(s).)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje